Real-World Analysis of the Enfortumab Vedotin-Ineligible criTeriA Assessment in Treatment-Naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma

被引：0
|
作者：
Miyake, Makito [1 ]
Nishimura, Nobutaka [1 ]
Oda, Yuki [1 ]
Shimizu, Takuto [1 ]
Iida, Kota [1 ]
Fujimoto, Kiyohide [1 ]
机构：
[1] Nara Med Univ, Dept Urol, Nara, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2025年
关键词：
chemotherapy; enfortumab vedotin; EVITA; mortality; pembrolizumab; survival; urinary bladder neoplasms;
D O I：
10.1111/iju.70040
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Gomez Rey, Gabriel
    CURRENT ONCOLOGY, 2024, 31 (09) : 5662 - 5676
  • [22] Nationwide Study of Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Urothelial Carcinoma in Hungary
    Maraz, Aniko
    Nagy, Bence
    Macher, Tamara
    Jesko, Jozsef
    Tischler, Erika
    Csongvai, Csaba
    Kearney, Mairead
    ADVANCES IN THERAPY, 2023, 40 (12) : 5475 - 5488
  • [23] Disitamab vedotin in combination with immune checkpoint inhibitors for locally and locally advanced bladder urothelial carcinoma: a two-center's real-world study
    Wei, Yongbao
    Zhang, Ruochen
    Yu, Chenbo
    Hong, Zhiwei
    Lin, Le
    Li, Tao
    Chen, Jianhui
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [24] Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World Data
    Miyake, Makito
    Nishimura, Nobutaka
    Shimizu, Takuto
    Ohnishi, Mikiko
    Kuwada, Masaomi
    Itami, Yoshitaka
    Inoue, Takeshi
    Ohnishi, Kenta
    Matsumoto, Yoshihiro
    Yoshida, Takanori
    Tatsumi, Yoshihiro
    Shinohara, Masatake
    Hori, Shunta
    Morizawa, Yosuke
    Gotoh, Daisuke
    Nakai, Yasushi
    Anai, Satoshi
    Torimoto, Kazumasa
    Aoki, Katsuya
    Fujii, Tomomi
    Tanaka, Nobumichi
    Fujimoto, Kiyohide
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 623 - 635
  • [25] Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan
    Kita, Yuki
    Otsuka, Hikari
    Ito, Katsuhiro
    Hara, Takuto
    Shimura, Soichiro
    Kawahara, Takashi
    Kato, Minoru
    Kanamaru, Sojun
    Inoue, Koji
    Ito, Hiroki
    Igarashi, Atsushi
    Sazuka, Tomokazu
    Takamatsu, Dai
    Hashimoto, Kohei
    Abe, Takashige
    Naito, Sei
    Matsui, Yoshiyuki
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    Kobayashi, Takashi
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (05) : 552 - 559
  • [26] The effectiveness and safety of RC48 alone or in combination with PD-1 inhibitors for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
    Ge, Huaixi
    Liu, Changxue
    Shen, Chengquan
    Hu, Ding
    Zhao, Xinzhao
    Wang, Yanhua
    Ge, Huimin
    Qin, Ruize
    Ma, Xiaocheng
    Wang, Yonghua
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [27] Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis
    Niegisch, Guenter
    Grimm, Marc-Oliver
    Hardtstock, Fraence
    Krieger, Julia
    Starry, Alexandra
    Osowski, Ulrike
    Guenther, Silke
    Deiters, Barthold
    Maywald, Ulf
    Wilke, Thomas
    Kearney, Mairead
    FUTURE ONCOLOGY, 2024, 20 (19) : 1351 - 1366
  • [28] Avelumab for the treatment of locally advanced or metastatic Merkel cell carcinoma-A multicenter real-world experience in Israel
    Averbuch, Itamar
    Stoff, Ronen
    Miodovnik, Mor
    Fennig, Shlomit
    Bar-Sela, Gil
    Yakobson, Alexander
    Daliot, Jonathan
    Asher, Natan
    Fenig, Eyal
    CANCER MEDICINE, 2023, 12 (11): : 12065 - 12070
  • [29] Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States
    Geynisman, Daniel M.
    Broughton, Edward
    Hao, Yi
    Zhang, Ying
    Le, Trong
    Huo, Stephen
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (05) : 195.e1 - 195.e11
  • [30] Efficacy and safety of combined treatment with pembrolizumab in patients with locally advanced or metastatic esophageal squamous cell carcinoma in the real world
    Zhang, Pei
    Hou, Xiaobin
    Cai, Boning
    Yu, Wei
    Chen, Jing
    Huang, Xiang
    Li, Ye
    Zeng, Mingyue
    Ren, Zhipeng
    Gabriel, Emmanuel
    Qu, Baolin
    Liu, Fang
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (12)
12345